Related Experiment Video
Updated: May 20, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Immunotherapy for glioma: promises and challenges
Seunggu J Han1, Corinna Zygourakis, Michael Lim
1Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143, USA.
Neurosurgery Clinics of North America
|July 4, 2012
Summary
Novel immunotherapies target high-grade gliomas by overcoming tumor-induced immune suppression. Strategies include cytokine therapy, passive immunotherapy, and active immunotherapy to enhance anti-tumor immune responses.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer therapy
Background:
- High-grade gliomas (HGGs) exhibit significant immune suppression within the brain.
- Tumors limit immune cell communication, secrete inhibitory molecules, and induce immune cell apoptosis.
- Understanding these mechanisms is crucial for developing effective cancer treatments.
Purpose of the Study:
- To explain how brain tumors suppress immune function.
- To define immunotherapeutic strategies to counteract tumor-associated immunosuppression.
- To review current and potential immunotherapy approaches for HGGs.
Main Methods:
- Review of mechanisms by which gliomas suppress immune function.
- Description of cytokine therapy, passive immunotherapy (serotherapy, adoptive immunotherapy), and active immunotherapy.
- Analysis of the potential of immunotherapy in treating high-grade gliomas.
Main Results:
- Gliomas employ multiple strategies to evade immune detection and destruction.
- Immunotherapeutic approaches aim to restore or enhance anti-tumor immunity.
- Current immunotherapies show mixed but promising results for HGG treatment.
Conclusions:
- Immunotherapy holds significant potential for treating high-grade gliomas.
- Overcoming tumor-induced immunosuppression is key to successful immunotherapy.
- Continued research and development are essential for advancing glioma immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...